# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Lou Gehrig (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET018-SYN-TD
- Date: 1939-05-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gavin Hollister, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for new patient with progressive weakness and loss of coordination: evaluation for a motor neuron disorder and its mimics, safety, and how he wants to receive results. **S**

## Objective

White cells: 6.8 10*3/uL; Hemoglobin: 15.2 g/dL; Platelets: 245 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 0.88 mg/dL; eGFR: 115 mL/min/1.73 m²; Glucose: 92 mg/dL; Calcium: 9.4 mg/dL; ALT: 32 U/L; AST: 30 U/L; Creatine kinase: 412 U/L (high); Vitamin B12: 512 pg/mL; TSH: 1.6 mIU/L; Hemoglobin A1c: 5.2%; Forced vital capacity (seated): 4.62 L; Forced vital capacity, percent predicted (seated): 90%; PHQ-2: 1. All results are synthetic.

BP 124/78 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 89.5 kg; BMI 26.7 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Progressive weakness and loss of coordination for about a year: fumbling with buttons and a bat, tripping on curbs, a fall on the ice in the winter, muscle cramps and twitching in the arms and thighs; no numbness, pain, double vision, or trouble speaking or swallowing. Examination: wasting of the hand muscles (left more than right), fasciculations in both arms and thighs, weakness of grip and of left ankle dorsiflexion, brisk reflexes with spread and a positive Hoffmann sign, normal sensation. Mixed upper and lower motor neuron signs; evaluation for motor neuron disease and its mimics begun, with neuromuscular neurology consultation booked. Strengths and supports remain part of the care plan. **S**

## Medication changes

- No medication changes. **S**

## Plan

- Evaluation of progressive weakness with mixed upper and lower motor neuron signs: blood count, metabolic panel with calcium, creatine kinase, vitamin B12, TSH, A1c, serum protein electrophoresis with immunofixation, and an HIV test; MRI of the brain and cervical spine; seated spirometry. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009); A proposal for new diagnostic criteria for ALS (Gold Coast criteria) (2020); El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis (2000) **S**
- Neuromuscular neurology consultation with EMG and nerve conduction studies for progressive weakness with mixed upper and lower motor neuron signs. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009); A proposal for new diagnostic criteria for ALS (Gold Coast criteria) (2020) **S**
- Safety while the evaluation proceeds: no competitive play or heavy lifting, a physical therapy assessment of balance and gait, home fall precautions (night lights, rails, no loose rugs), and a same-day call for any trouble swallowing or breathing; results given to him first, in person. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009) **S**
